(Q35189666)

7 August 2017

1 reference

title

Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment (English)

1 reference

7 August 2017

1 reference

Dominique L Musselman

1

1 reference

7 August 2017

Ephi Betan

2

1 reference

7 August 2017

Hannah Larsen

3

1 reference

7 August 2017

Lawrence S Phillips

4

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

7 August 2017

Biological Psychiatry

1 reference

7 August 2017

54

1 reference

7 August 2017

317-329

1 reference

7 August 2017

3

1 reference

Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

The prevalence of comorbid depression in adults with diabetes: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Reduction of prefrontal cortex glucose metabolism common to three types of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

An Inventory for Measuring Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Acute phase proteins in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

The association between chronic diseases and depressive symptomatology in older Mexican Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Long-term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: influence on muscle glycogen synthase and insulin receptor kinase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Neuroendocrine and amine studies in affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Interpersonal predictors of HbA(1c) in patients with type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

7 January 2021

Depression and Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Feast and famine: critical role of glucocorticoids with insulin in daily energy flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Association of depression and diabetes complications: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Distribution and phenotype of neurons containing the ATP-sensitive K+ channel in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Depression and risk for onset of type II diabetes. A prospective population-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Epidemiologic evidence for the relation between socioeconomic status and depression, obesity, and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Contributors to depression in Latino and European-American patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Gender, depression, and one-year prognosis after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Depressive symptoms and metabolic control in African-Americans with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Prevalence of depression in adults with diabetes. An epidemiological evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Cognition and synaptic plasticity in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Relationship between depressive symptoms and diabetes among native Hawaiians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Psychiatric illness and cardiovascular disease risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Tumor necrosis factor alpha: a key component of the obesity-diabetes link

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Regional cerebral glucose metabolism in major depressive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Population-based care of depression: effective disease management strategies to decrease prevalence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Depressive symptoms and occurrence of type 2 diabetes among Japanese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Sickness behavior as a new target for drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Cerebral metabolism and atrophy in huntington's disease determined by18FDG and computed tomographic scan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Glucosensing neurons do more than just sense glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Psychosocial factors and complications of IDDM. The Pittsburgh Epidemiology of Diabetes Complications Study. VIII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Depression in diabetics: A critical appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Predicting response to cognitive behavior therapy of depression in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Depression in adults with diabetes. Results of 5-yr follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Depression in adults with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Cumulative impact of sustained economic hardship on physical, cognitive, psychological, and social functioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Increased serum interleukin-1-receptor-antagonist concentrations in major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Lifetime prevalence of major depression and its effect on treatment outcome in obese type II diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Left prefrontal glucose hypometabolism in the depressed state: a confirmation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Depression in patients with cancer. Diagnosis, biology, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Studies of hormone action in the hippocampal formation: possible relevance to depression and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Hypoglycemia in patients with type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Clinical depression and inflammatory risk markers for coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Intravenous Glucose Tolerance Test in Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Clinical practice. Initial management of glycemia in type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Fluoxetine in the treatment of obese type 2 diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Influence of socio-economic deprivation on the prevalence and outcome of depression in primary care: the Hampshire Depression Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Personality and risk of cancer: 20-year follow-up of the Western Electric Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Levels and risks of depression and anxiety symptomatology among diabetic adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Neighborhood Disadvantage and Adult Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Studies of metabolic compartmentation and glucose transport using in vivo MRS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Bupropion and sexual function: a placebo-controlled prospective study on diabetic men with erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

The expression of TNF alpha by human muscle. Relationship to insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

How does the prevalence of specific morbidities compare with measures of socio-economic status at small area level?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Prevalence of impaired glucose tolerance among children and adolescents with marked obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Psychological counselling in problematic diabetes: does it help?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Hostility, race, and glucose metabolism in nondiabetic individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Effects of Nefazodone on Body Weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Depression, glucose tolerance, peripheral glucose uptake and their alterations under the influence of anti-depressive drugs of the hydrazine type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Mental well-being in people with non-insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Insulin resistance after oral glucose tolerance testing in patients with major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Glucose Metabolism in Unipolar Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Endotoxin produces a depressive-like episode in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

A SELF-RATING DEPRESSION SCALE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

Glucose transporter isoform expression in Huntington's disease brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Psychiatric illness in diabetes mellitus. Relationship to symptoms and glucose control.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900569-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(03)00569-9

1 reference

7 August 2017

1 reference